Krystal Biotech
KRYS
KRYS
188 hedge funds and large institutions have $2.76B invested in Krystal Biotech in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 89 increasing their positions, 52 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
+5
Holders Change %
+2.73%
% of All Funds
3%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
21
Increased
89
Reduced
52
Closed
14
Calls
$22.5M
Puts
$38.5M
Net Calls
-$16M
Net Calls Change
-$22M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$80.5M |
| 2 |
Jennison Associates
New York
|
+$32.8M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$32.2M |
| 4 |
FAM
Fred Alger Management
New York
|
+$19M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$16.1M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$65.3M |
| 2 |
AG
Artal Group
Luxembourg
|
-$41.1M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$27.1M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.9M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$19M |
